Showing results (281-290 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|March 24, 2022
Rapid and durable response to fifth-line lorlatinib plus olaparib in an ALK -rearranged, BRCA2-mutated metastatic lung adenocarcinoma patient with critical tracheal stenosis: a case reportChang'e Jin, Zhengqiang He, Min Guo, et al.
Anti-Cancer Drugs|March 24, 2022
Poor response to selpercatinib plus crizotinib in a rearranged during transfection fusion-positive patient with acquired selpercatinib-resistant MNNG HOS transforming amplification: a case reportZhaoting Meng, Cuicui Zhang, Ran Zuo, et al.
Anti-Cancer Drugs|August 15, 2018
A novel hedgehog inhibitor for the treatment of hematological malignanciesPeng Lin, Yuanming He, Guodong Chen, et al.
Anti-Cancer Drugs|June 19, 2018
In-vitro effects of the FS50 protein from salivary glands of Xenopsylla cheopis on voltage-gated sodium channel activity and motility of MDA-MB-231 human breast cancer cellsBei Zhang, Zhenghui Deng, Baishuang Zeng, et al.
Anti-Cancer Drugs|May 22, 2018
Role of LKB1 in migration and invasion of Cr(VI)-transformed human bronchial epithelial Beas-2B cellsJian Lu, Zhongping Zhou, Miaomiao Tang, et al.
Anti-Cancer Drugs|July 27, 2018
Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer modelsAnna Capasso, Todd M Pitts, Peter J Klauck, et al.
Anti-Cancer Drugs|December 10, 1999
Population pharmacokinetic approach to compare oral and i.v. administration of etoposideG Würthwein, S Krümpelmann, B Tillmann, et al.
Anti-Cancer Drugs|December 10, 1999
Phase I and pharmacologic study of BMS-181174 given as a 6 h infusion every 4 weeks to patients with advanced solid tumorsA S Planting, J H Schellens, M E van der Burg, et al.
Anti-Cancer Drugs|December 10, 1999
Antitumor activity of KF22678, a novel thioester derivative of leinamycinT Ashizawa, K Kawashima, Y Kanda, et al.
Anti-Cancer Drugs|June 23, 1999
Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinomaG Gravis, F Pech-Gourgh, P Viens, et al.
Pageof 464